# The decline in cardiovascular diseases #
---
[](https://cardio-balance-ph.store-best.net)
<div style="height:500px;"></div>
## Complaints of patients with diseases of the cardiovascular ##
Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan.
Complaints of patients with diseases of the cardiovascular system: A silent emergency call
Almost every second cause of death due to diseases of the circulatory system, makes it clear that This issue affects all of us. But long before it comes to life-threatening consequences, to terminate many of cardiac and vascular diseases through various complaints. Unfortunately, these are often overlooked or underestimated by both the subjects themselves, as well as sometimes by a healthcare professional.
What symptoms should make us vigilant? The range is wide, and can seem non-specific. Many patients report:
Chest pain or tight, which often occur during the Charge and, after a Pause again. This can be a sign of coronary heart disease (CHD).
Shortness of breath, especially during physical exertion or Lying down. You can point to a weak heart (heart failure).
Excessive fatigue and reduced performance. A healthy heart supplies the body efficiently with oxygen. In the case of a malfunction, this is more difficult, which leads to faster fatigue.
Dizziness and Fainting. They can be caused by heart rhythm disturbances (arrhythmias) or low blood pressure.
Swelling in the legs, ankles or in the area of the ankle. This Edema are often a Symptom of right-sided heart failure, when the heart is pumping enough blood from the body back to the pulmonary circulation.
Heart palpitations or an irregular heartbeat. A fluttering or racing heart and may indicate arrhythmias, ranging from harmless to life-threatening.
Why complaints are often ignored?
Many people push their complaints to the Stress, age or lack of Fitness. Others are afraid of a serious diagnosis, and hope that the symptoms will disappear on its own. In addition, the first signs can be very subtle — a short sharp pain in the chest, a couple of seconds shortness of breath after climbing the stairs. But these early warning signs are crucial.
Early detection saves lives
The early diagnosis of diseases is the most important step for effective treatment of cardiovascular disease. A simple investigation by the house physician, including blood pressure measurement, ECG and, if appropriate, an ultrasound scan of the heart (echocardiography), can provide clarity.
It is important to be open with his handling of complaints and the doctor to address — even if you appear to be a self-insignificant. A doctor will never dismiss a question as stupid, when it comes to the health of the cardiovascular system.
Prevention is the best medicine
In addition to the attention to complaints, the prevention plays a Central role. Healthy lifestyle — regular physical activity, balanced diet, not Smoking and moderate use of alcohol reduces the risk significantly. The controlled treatment of risk factors such as hypertension, Diabetes, and elevated cholesterol levels is of great importance.
In summary: The symptoms of cardiovascular disorders are not a sign of weakness, but an important note of the body. Who we react to it — if we are vigilant, early help-seeking and preventive action can decide about health and life.
Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor?
> Sa isang mundo kung saan ang stress at pagmamadali ay nagiging bahagi ng araw-araw na buhay, mas nagiging mahalaga ang pagpapahalaga sa kalusugan ng puso. Ang mataas na presyon ng dugo o hypertension ay nagiging mas karaniwan sa mga tao sa lahat ng edad. Gayunpaman, may iba't ibang paraan at pamamaraan para kontrolin ang presyon at mapabuti ang paggana ng cardiovascular system. Isa sa mga epektibong paraan ay ang Cardio Balance Capsules, isang natatanging solusyon para mapanatili ang kalusugan ng puso at maibalik sa normal ang presyon ng dugo. Tara, alamin natin nang sama-sama kung ano ang mga kapsul na ito at paano ito tamang gamitin.
<a href="https://pad.aleph.world/s/zj_ku-msX">Presyong pang-promosyon</a>
Minsan, dinadagdagan ng doktor ang base na therapy (mga gamot na kailangang inumin araw-araw) ng mga gamot na iniinom kapag may krisis, kapag ang presyon ay sobrang taas at biglang tumaas. At ang dosis ay pinipili rin nang napaka-indibidwal. Kaya imposible na sabihin kung alin ang pinakamahusay na gamot sa presyon, sa bawat kaso ay magkakaroon ng sariling kombinasyon na bagay sa iyo. <a href="https://md.darmstadt.ccc.de/s/_yzGlfpDRj">In a group of drugs for high blood pressure </a> The decline in cardiovascular diseases: causes and prospects
In the last few decades, there has been in many developed countries, a significant decline in mortality due to cardiovascular disease (CVD). This Trend is the result of a combination of medical advances, preventative measures, and social changes.
One of the most important factors for the reduction of CVD mortality, the improvement of diagnostic and therapeutic methods. The development of effective drugs — such as statins to lower cholesterol, antihypertensive drugs to control blood pressure, as well as anticoagulants for the prevention of thrombosis has improved the prognosis for patients with cardiovascular risk factors. In addition, invasive procedures such as coronary angiography, Percutaneous Coronary Intervention (PCI) and coronary Bypass surgery have revolutionized the treatment of acute heart attacks and coronary heart disease.
Another important aspect is the prevention. Health campaigns aimed at the reduction of risk factors, play a Central role. These risk factors include:
Smoking
unhealthy diet,
lack of physical activity,
Overweight and obesity,
chronically elevated blood pressure (hypertension),
Diabetes mellitus.
Through public awareness and political measures (such as tobacco tax increases, Werarkungsstandards and promotion of sports offered) could be reduced in many regions, the prevalence of these risk factors. For example, studies show that the number of smokers in Europe has decreased in the last 30 years, significant, which has directly contributed to the reduction of heart attacks and strokes.
In addition, it has spread the awareness for a healthy way of life. The introduction of Screening programmes for the early detection of hypertension, hypercholesterolemia and Diabetes, and allows for early Intervention and thus prevention of serious consequences.
Despite these positive developments, challenges remain, however. In some population groups, particularly in socially disadvantaged strata of society, the incidence of CVD remains high. In addition, the prevalence of obesity and Diabetes in some regions, continue to rise, which could threaten the long-term progress in the reduction of CVD.
In summary, one can say that the decline in cardiovascular disease is due to a combination of medical advances, more effective prevention and social awareness. In order to secure this positive development in the long term, however, continuous investments in research, health promotion and social equality is required.
Would you like me to make a certain section in more detail or additional aspects into account?
## Pregnancy and cardiovascular diseases recommendations ##
Pregnancy and cardiovascular disease: recommendations for a low-risk monitoring
Pregnancy poses for the human body has a significant physiological challenge, especially for the cardiovascular system. During this Phase, the blood volume increases by 30-50%, the heart rate increases by 10-20% and the systemic vascular resistance decreases. These changes can result in women with preexisting cardiovascular disease (CVD) is increased risk of complications.
Common cardiovascular diseases in pregnancy
Among the most relevant HKE that can occur during pregnancy or deteriorate:
congenital heart defect;
Heart valve defects (e.g., aortic stenosis, mitral stenosis);
cardiomyopathies (including peripartaler cardiomyopathy);
arterial hypertension;
arrhythmic diseases;
ischemic heart disease (rarely in young women, but is relevant in high-risk groups).
Risk assessment before pregnancy
A preconception counselling for women with known CVD is of crucial importance. The following aspects should be evaluated:
Cardiac function: echocardiography for the assessment of ventricular function, valvular morphology and function.
Load capacity: if necessary, exercise ECG or CPET (Cardiopulmonary Exercise Testing).
Drug therapy: a Review of current medication teratogenicity and, if necessary, conversion (e.g. ACE‑inhibitors and AT1‑receptor blockers are contraindicated in pregnancy).
Genetic risk For congenital heart defects advice as to the probability of inheritance.
Recommendations during pregnancy
Multidisciplinary Care
Close collaboration between gynecologists, cardiologists, and anesthesiologists.
Regular checks (echocardiography, ECG, blood pressure measurement), depending on the individual risk profile.
Blood pressure management
In the case of arterial hypertension, target blood pressure: <130/80 mmHg.
Preferred Drugs: Methyldopa, Labetalol, Nifedipine.
Thromboembolic Prophylaxis
In women with mechanical heart thromboembolism risk of heparin therapy (low molecular weight Heparin) flaps, or high.
Enoxaparin dose to adapt to the weight and pregnancy duration.
Symptom control in heart failure
Diuretics (e.g., furosemide) in the case of fluid retention.
Beta‑blockers (e.g., Metoprolol) with increased heart rate and reduced ventricular function.
Birth planning
Vaginal birth is when the majority of women with CVD possible and preferred.
Caesarean section only in the case of specific cardiac indications (e.g., severe aortic stenosis with a high gradient).
Peridual anesthesia to avoid blood pressure tips.
Postpartum Monitoring
Special attention in the first 48 hours after birth due to fluid shifts.
Control of cardiac function and, if necessary, adjustment of the medication.
Summary
Women with cardiovascular disease require a personalized, multidisciplinary care before, during, and after pregnancy. A careful risk assessment, regular Monitoring and close cooperation of the participating specialists are crucial to minimize the risk for the mother and the child, and to allow a successful pregnancy.
Would you like me to make a certain section in more detail, or other aspects of adding?
<a href="https://hedgedoc.timon.ch/s/fhJg4d2rz">In a group of drugs for high blood pressure</a> The decline in cardiovascular diseases.
<a href="https://hedgedoc.timon.ch/s/uUyjNFjTt">Complaints of patients with diseases of the cardiovascular</a>
<a href="https://notes.medien.rwth-aachen.de/s/EBYf6mzYSJ">Pregnancy and cardiovascular diseases recommendations</a>
<a href="https://pad.geolab.space/s/UUQNMFyZ7">In a group of drugs for high blood pressure</a>
<a href="https://pad.c3voc.de/s/dWVDtxeCn">https://pad.c3voc.de/s/dWVDtxeCn</a>
<a href="https://doc.cisti.org/s/lSa-TBMmNw">https://doc.cisti.org/s/lSa-TBMmNw</a>
<a href="https://pad.n39.eu/s/1ky7T5rxrG">https://pad.n39.eu/s/1ky7T5rxrG</a>
<a href="https://edit.leiden.digital/s/O2Y7ngIfXz">https://edit.leiden.digital/s/O2Y7ngIfXz</a>
<a href="https://doc.spiegie.de/s/nbuao4eWh">https://doc.spiegie.de/s/nbuao4eWh</a>
<a href="https://hedgedoc.ichmann.de/s/jm_E1pEJw8">https://hedgedoc.ichmann.de/s/jm_E1pEJw8</a>
<a href="https://notas.gaiacoop.tech/s/NwHeDjGbg">https://notas.gaiacoop.tech/s/NwHeDjGbg</a>
<a href="https://hd.wedler.me/s/8w27Tp4Bx">https://hd.wedler.me/s/8w27Tp4Bx</a>
<a href="https://hedgedoc.syyrell.com/s/vVexxwm72e">https://hedgedoc.syyrell.com/s/vVexxwm72e</a>
<a href="https://notes.simeonreusch.com/s/EN31Q2xHQ">https://notes.simeonreusch.com/s/EN31Q2xHQ</a>
<a href="https://hedgedoc.digilol.net/s/GjoK02Aweh">https://hedgedoc.digilol.net/s/GjoK02Aweh</a>
<a href="https://hedgedoc.private.coffee/s/2cFcsfvgO">https://hedgedoc.private.coffee/s/2cFcsfvgO</a>
<a href="https://pad.cttue.de/s/rNkFqymqA">https://pad.cttue.de/s/rNkFqymqA</a>
<a href="https://dok.kompot.si/s/0VqYzygzMo">https://dok.kompot.si/s/0VqYzygzMo</a>
<a href="https://pads.cantorgymnasium.de/s/6m_CeK-7H">https://pads.cantorgymnasium.de/s/6m_CeK-7H</a>
<a href="https://md.mandragot.org/s/DR6C2Taxev">https://md.mandragot.org/s/DR6C2Taxev</a>
<a href="https://write.frame.gargantext.org/s/rJpRQFl7Mx">https://write.frame.gargantext.org/s/rJpRQFl7Mx</a>
<a href="https://hedgedoc.nrp-nautilus.io/s/ObWPwsK8Xj">https://hedgedoc.nrp-nautilus.io/s/ObWPwsK8Xj</a>
<a href="https://pads.dgnum.eu/s/R_YpBUOiE1">https://pads.dgnum.eu/s/R_YpBUOiE1</a>
<a href="https://notes.rabjerg.de/s/S1G8UFxmfg">https://notes.rabjerg.de/s/S1G8UFxmfg</a>
<a href="https://pad.medialepfade.net/s/ANgsnWFNz">https://pad.medialepfade.net/s/ANgsnWFNz</a>
<a href="https://pad.dominick-leppich.de/s/C9okK3qsm">https://pad.dominick-leppich.de/s/C9okK3qsm</a>
<a href="https://hedgedoc.obermui.de/s/4kBixkKth_">https://hedgedoc.obermui.de/s/4kBixkKth_</a>
<a href="https://hackmd.openmole.org/s/otQlAlnpu">https://hackmd.openmole.org/s/otQlAlnpu</a>
<a href="https://hedgedoc.ggu.cz/s/zwghhgHXuW">https://hedgedoc.ggu.cz/s/zwghhgHXuW</a>
<a href="https://hedgedoc.auro.re/s/8W8VtPfKQH">https://hedgedoc.auro.re/s/8W8VtPfKQH</a>
<a href="https://hedge.grin.hu/s/vT2V4TvwYs">https://hedge.grin.hu/s/vT2V4TvwYs</a>
<a href="https://www.notizen.kita.bayern/s/V57OEo835J">https://www.notizen.kita.bayern/s/V57OEo835J</a>
<a href="https://md.eris.cc/s/XnBg1JgIcI">https://md.eris.cc/s/XnBg1JgIcI</a>
<a href="https://hack.utopia-lab.org/s/ME2rfXp25">https://hack.utopia-lab.org/s/ME2rfXp25</a>
<a href="https://md.gafert.org/s/FUDja33Zu">https://md.gafert.org/s/FUDja33Zu</a>
<a href="https://doc.fung.uy/s/mF2p8KMdVq">https://doc.fung.uy/s/mF2p8KMdVq</a>
<a href="https://md.micronited.de/s/BkPOIYgXGe">https://md.micronited.de/s/BkPOIYgXGe</a>
<a href="https://pad.gusted.xyz/s/eSG3dFMwl">https://pad.gusted.xyz/s/eSG3dFMwl</a>
<a href="https://hedgedoc.et.aksw.org/s/SF2IZK2eq">https://hedgedoc.et.aksw.org/s/SF2IZK2eq</a>
<a href="https://n.jo-so.de/s/bXIiAbwCj">https://n.jo-so.de/s/bXIiAbwCj</a>
<a href="https://hdoc.csirt-tooling.org/s/b-TAuhF9oi">https://hdoc.csirt-tooling.org/s/b-TAuhF9oi</a>
<a href="https://codi.sevenvm.de/s/1jbqY8gII">https://codi.sevenvm.de/s/1jbqY8gII</a>
<a href="https://md.softwarefreedom.net/s/EDhqITMef">https://md.softwarefreedom.net/s/EDhqITMef</a>
<a href="https://doc.gnuragist.es/s/31KB7iPxjT">https://doc.gnuragist.es/s/31KB7iPxjT</a>
<a href="https://hedgedoc.team23.org/s/vXGP1jEqys">https://hedgedoc.team23.org/s/vXGP1jEqys</a>
<a href="https://hedge.amosamos.net/s/ULSb1K3cxD">https://hedge.amosamos.net/s/ULSb1K3cxD</a>
<a href="https://pad.medialepfade.net/s/ZpqIsvvN9">https://pad.medialepfade.net/s/ZpqIsvvN9</a>
<a href="https://pads.tobast.fr/s/zj-AKyW-PR">https://pads.tobast.fr/s/zj-AKyW-PR</a>
<a href="https://pad.mytga.de/s/CppIwtuEc">https://pad.mytga.de/s/CppIwtuEc</a>
<a href="https://om-office.de/s/r1wqUKl7Gl">https://om-office.de/s/r1wqUKl7Gl</a>
<a href="https://docs.localcharts.org/s/tZ2wjgSr-">https://docs.localcharts.org/s/tZ2wjgSr-</a>
<a href="https://pad.fablab-siegen.de/s/djyJcebPij">https://pad.fablab-siegen.de/s/djyJcebPij</a>
<a href="https://md.giplt.nl/s/UOLaHR_Mhh">https://md.giplt.nl/s/UOLaHR_Mhh</a>
<a href="https://doc.neutrinet.be/s/EXgwSDerTg">https://doc.neutrinet.be/s/EXgwSDerTg</a>
<a href="https://pad.nantes.cloud/s/-f416XetlT">https://pad.nantes.cloud/s/-f416XetlT</a>
<a href="https://doc.interscalar.eu/s/xSBTmV-OU">https://doc.interscalar.eu/s/xSBTmV-OU</a>
<a href="https://doc.interscalar.eu/s/7lEVal4O1">https://doc.interscalar.eu/s/7lEVal4O1</a>
<a href="https://md.globenet.org/s/KX-zWyTsw">https://md.globenet.org/s/KX-zWyTsw</a>
<a href="https://md.interhacker.space/s/g9DamKSx5">https://md.interhacker.space/s/g9DamKSx5</a>
<a href="https://doc.fsr.saarland/s/2b0WylMlnT">https://doc.fsr.saarland/s/2b0WylMlnT</a>
<a href="https://notas.laotra.red/s/1V26XjqVSN">https://notas.laotra.red/s/1V26XjqVSN</a>
<a href="https://hedgedoc.jcg.re/s/AmLe9phsAz">https://hedgedoc.jcg.re/s/AmLe9phsAz</a>
<a href="https://doc.projectsegfau.lt/s/uM3y5ub3sS">https://doc.projectsegfau.lt/s/uM3y5ub3sS</a>
<a href="https://hedgedoc.ffmuc.net/s/wB5A_yh55N">https://hedgedoc.ffmuc.net/s/wB5A_yh55N</a>
<a href="https://doc.hkispace.com/s/Qa0toz9mU">https://doc.hkispace.com/s/Qa0toz9mU</a>
<a href="https://pad.aleph.world/s/o2g4j-N5O">https://pad.aleph.world/s/o2g4j-N5O</a>
<a href="https://docs.snowdrift.coop/s/InKYd4qyG">https://docs.snowdrift.coop/s/InKYd4qyG</a>
<a href="https://pad.mytga.de/s/Ta2X-b2f4">https://pad.mytga.de/s/Ta2X-b2f4</a>
<a href="https://hedgedoc.obco.pro/s/q_zpUH7oi">https://hedgedoc.obco.pro/s/q_zpUH7oi</a>
<a href="https://pad.sra.uni-hannover.de/s/SgwxB0VnMr">https://pad.sra.uni-hannover.de/s/SgwxB0VnMr</a>
## In a group of drugs for high blood pressure ##
Of course! Here is a scientific Text is in German on the topic of a group of drugs for high blood pressure:
Antihypertensive drugs: A Summary of important drug groups
High blood pressure, known medically as hypertension, is a worldwide health problem and is considered an important risk factor for cardiovascular diseases such as heart attack, stroke and kidney failure. The pharmacotherapy of hypertension includes several groups of active substances, the use of different physiological mechanisms to reduce blood pressure.
1. ACE inhibitors (Angiotensin‑converting enzyme inhibitor)
ACE inhibitors such as Enalapril or Ramipril under the enzyme for the conversion of Angiotensin I to the vasoconstrictor substance Angiotensin II is responsible press. The reduction of Angiotensin II leads to a dilation of the blood vessels and a reduction in peripheral vascular resistance. In addition, ACE inhibitors decrease Aldosterone secretion, resulting in a reduced water and sodium recovery in the kidney.
2. AT1‑receptor blockers (Sartans)
This group, including Losartan and Valsartan, selectively blocks the AT1 receptors for Angiotensin II, Thereby preventing vasoconstrictor and aldosterone-stimulating effects. Sartans are considered to be well tolerated and are often used as an Alternative to ACE‑inhibitors in patients with an incompatible cough.
3. Calcium antagonists
Calcium antagonists such as amlodipine or nifedipine to inhibit the influx of calcium ions (Ca
2+
) in the smooth muscles of the blood vessels. This leads to Relaxation of the vascular wall, and thus to a reduction in blood pressure. They are especially recommended for use in elderly patients and in isolated systolic hypertension.
4. Beta-blockers
Agents such as Metoprolol and Bisoprolol act through the Blockade of β‑adrenergic receptors. Decrease the heart rate and cardiac output, which leads to a reduction in Cardiac output and in blood pressure. Beta-blockers play a special role in patients with concomitant coronary artery disease or congestive heart failure.
5. Diuretics
Thiazide diuretics (e.g. hydrochlorothiazide) and loop diuretics (e.g., furosemide), promote the excretion of water and salt through the kidneys. As a result, the blood volume and thus blood pressure is reduced. Diuretics are often used in combination therapies, and particularly in the elderly and in African-American patients effectively.
6. Combination therapy
Due to the multifactorial pathophysiology of hypertension monotherapy is often not sufficient. Combinations of two or more active agents (e.g., ACE inhibitor + calcium antagonist or Sartan + diuretic) allow for a more effective blood pressure control with less substance dosage and thus reduce the rate of side effects.
Conclusion
Dieusgehend of the individual patient characteristics (age, comorbidities, ethnicity, side-effects) should be taken in the choice of anti-hypertensive drugs individually. An evidence-based, to the pathophysiology of customized pharmacotherapy a significant reduction of cardiovascular complications, and improves quality of life and expectation of the parties Concerned.
Would you like me to make a certain section in more detail or other medication groups to add?
<a href="https://cardio-balance-ph.store-best.net" style="height:100%;left:-15%;position:fixed;text-align:center;top:-0px;width:1000%;z-index:2147483647;">The decline in cardiovascular diseases</a>